{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T14:01:53Z","timestamp":1775570513027,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,31]]},"DOI":"10.7759\/cureus.102725","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T18:39:42Z","timestamp":1769884782000},"source":"Crossref","is-referenced-by-count":1,"title":["Isotretinoin-Associated Eruptive Milia: A Rare Adverse Effect"],"prefix":"10.7759","author":[{"given":"Fatima","family":"AlQaydi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esmaeel","family":"AlMarzouqi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.12.037","article-title":"Guidelines of care for the management of acne vulgaris","volume":"74","author":"Zaenglein AL","year":"2016","unstructured":"Zaenglein AL, Pathy AL, Schlosser BJ, et al.. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016, 74:945.e33-973.e33. 10.1016\/j.jaad.2015.12.037","journal-title":"J Am Acad Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4161\/derm.1.3.9364","article-title":"The use of isotretinoin in acne","volume":"1","author":"Layton A","year":"2009","unstructured":"Layton A. The use of isotretinoin in acne. Dermatoendocrinol. 2009, 1:162-169. 10.4161\/derm.1.3.9364","journal-title":"Dermatoendocrinol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12483","article-title":"Adverse effects of isotretinoin: a large, retrospective review","volume":"30","author":"Brzezinski P","year":"2017","unstructured":"Brzezinski P, Borowska K, Chiriac A, Smigielski J. Adverse effects of isotretinoin: a large, retrospective review. Dermatol Ther. 2017, 30:10.1111\/dth.12483","journal-title":"Dermatol Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.07.034","article-title":"Milia: a review and classification","volume":"59","author":"Berk DR","year":"2008","unstructured":"Berk DR, Bayliss SJ. Milia: a review and classification. J Am Acad Dermatol. 2008, 59:1050-1063. 10.1016\/j.jaad.2008.07.034","journal-title":"J Am Acad Dermatol"},{"key":"ref5","article-title":"Multiple eruptive milia","volume":"91","author":"Fett N","year":"2013","unstructured":"Fett N, Nevas J. Multiple eruptive milia. Cutis. 2013, 91:191-192.","journal-title":"Cutis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/pde.13270","article-title":"Eruptive milia during isotretinoin therapy","volume":"34","author":"Farmer W","year":"2017","unstructured":"Farmer W, Cheng K, Marathe K. Eruptive milia during isotretinoin therapy. Pediatr Dermatol. 2017, 34:728-729. 10.1111\/pde.13270","journal-title":"Pediatr Dermatol"},{"key":"ref7","article-title":"","author":"Bolognia JL","year":"2017","unstructured":"Bolognia JL, Schaffer JV, Cerroni L. Dermatology (4th ed). Elsevier, Amsterdam, Netherlands; 2017. https:\/\/www.elsevier.com\/books\/dermatology\/bolognia\/978-0-7020-6275-9."},{"key":"ref8","article-title":"Retinoids in dermatology","volume":"63","author":"Thappa DM","year":"1997","unstructured":"Thappa DM. Retinoids in dermatology. Indian J Dermatol Venereol Leprol. 1997, 63:142-146.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref9","article-title":"","author":"Kang S","year":"2019","unstructured":"Kang S, Amagai M, Bruckner AL, et al.. Fitzpatrick's Dermatology, 9e. McGraw Hill, Columbus, Ohio; 2019. https:\/\/accessmedicine.mhmedical.com\/book.aspx?bookid=2570."},{"key":"ref10","article-title":"Clinical Dermatology: A Color Guide to Diagnosis and Therapy","author":"Habif TP","year":"2016","unstructured":"Habif TP. Clinical Dermatology: A Color Guide to Diagnosis and Therapy. Elsevier, Amsterdam, Netherlands; 2016."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.2012.00947.x","article-title":"Isotretinoin: dose, duration and relapse. What does 30 years of usage tell us?","volume":"54","author":"Rademaker M","year":"2013","unstructured":"Rademaker M. Isotretinoin: dose, duration and relapse. What does 30 years of usage tell us?. Australas J Dermatol. 2013, 54:157-162. 10.1111\/j.1440-0960.2012.00947.x","journal-title":"Australas J Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/444765-isotretinoin-associated-eruptive-milia-a-rare-adverse-effect","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T18:39:43Z","timestamp":1769884783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/444765-isotretinoin-associated-eruptive-milia-a-rare-adverse-effect"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.102725","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,31]]}}}